This Notice of Change announces the participation of the National Institute of Neurological Disorders and Stroke (NINDS) in the Notice of Funding Opportunity,"Bioengineering Research Grants (BRG) (R01 ...
ALSP, Inc. is developing a small molecule drug for Alzheimer's Disease. As an employee of this company, I have a financial interest in the success of it's drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results